Calls to revamp contraceptive leaflet
10th July 2015
By Alice Klein
The TGA wants all oral contraceptives to come with clearer information about clotting risks, particularly for the newer progestogen products.
In a statement released on Tuesday, the TGA said that an easy-to-understand comparator of different pills should be included in all product information leaflets.
The regulator said that they accepted the conclusions of a recent report by the European Medicines Agency, which explained that the type of progestogen influenced the risks of venous thromboembolism and arterial thromboembolism (ATE) associated with contraceptive pills.